Literature DB >> 34127807

RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article.

Asiya Kamber Zaidi1,2, Puya Dehgani-Mobaraki3.   

Abstract

Entities:  

Year:  2021        PMID： 34127807      PMCID： PMC8203399          DOI： 10.1038/s41429-021-00430-5

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
The Editor-in-Chief has retracted this article. Following publication, concerns were raised regarding the methodology and the conclusions of this review article. Postpublication review confirmed that while the review article appropriately describes the mechanism of action of ivermectin, the cited sources do not appear to show that there is clear clinical evidence of the effect of ivermectin for the treatment of SARS-CoV-2. The Editor-in-Chief therefore no longer has confidence in the reliability of this review article. None of the authors agree to this retraction. The online version of this article contains the full text of the retracted article as Supplementary Information. Former article version
  10 in total

Review 1.  Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19.

Authors:  A D Santin; D E Scheim; P A McCullough; M Yagisawa; T J Borody
Journal:  New Microbes New Infect       Date:  2021-08-03

2.  Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants.

Authors:  Océane Delandre; Mathieu Gendrot; Priscilla Jardot; Marion Le Bideau; Manon Boxberger; Céline Boschi; Isabelle Fonta; Joel Mosnier; Sébastien Hutter; Anthony Levasseur; Bernard La Scola; Bruno Pradines
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-02

3.  Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints.

Authors:  Marko Jukič; Katarina Kores; Dušanka Janežič; Urban Bren
Journal:  Front Chem       Date:  2021-12-28       Impact factor: 5.221

4.  Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.

Authors:  Lucy Kerr; Flavio A Cadegiani; Fernando Baldi; Raysildo B Lobo; Washington Luiz O Assagra; Fernando Carlos Proença; Pierre Kory; Jennifer A Hibberd; Juan J Chamie-Quintero
Journal:  Cureus       Date:  2022-01-15

Review 5.  Exploration of marine natural resources in Indonesia and development of efficient strategies for the production of microbial halogenated metabolites.

Authors:  Hiroyuki Yamazaki
Journal:  J Nat Med       Date:  2021-08-20       Impact factor: 2.343

Review 6.  CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target.

Authors:  Tapan Behl; Ishnoor Kaur; Lotfi Aleya; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Simona Bungau
Journal:  Sci Total Environ       Date:  2021-12-01       Impact factor: 7.963

Review 7.  Repurposing the drug, ivermectin, in COVID-19: toxicological points of view.

Authors:  Farshad M Shirazi; Roya Mirzaei; Samaneh Nakhaee; Amir Nejatian; Shokouh Ghafari; Omid Mehrpour
Journal:  Eur J Med Res       Date:  2022-02-05       Impact factor: 2.175

Review 8.  Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.

Authors:  Theo Rein
Journal:  J Cell Biochem       Date:  2021-10-20       Impact factor: 4.480

9.  Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects.

Authors:  Lucy Kerr; Fernando Baldi; Raysildo Lobo; Washington Luiz Assagra; Fernando Carlos Proença; Juan J Chamie; Jennifer A Hibberd; Pierre Kory; Flavio A Cadegiani
Journal:  Cureus       Date:  2022-08-31

Review 10.  Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic.

Authors:  Nadezhda Ivanova; Yoana Sotirova; Georgi Gavrailov; Krastena Nikolova; Velichka Andonova
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.